Antagonists of activin-ActRIIa and uses for increasing red blood cell levels

Details for Australian Patent Application No. 2009262968 (hide)

Owner Acceleron Pharma Inc.

Inventors Sherman, Matthew L.; Seehra, Jasbir; Borgstein, Niels

Agent Shelston IP

Pub. Number AU-A-2009262968

PCT Pub. Number WO2009/158033

Priority 61/133,368 26.06.08 US

Filing date 26 June 2009

Wipo publication date 30 December 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/38 (2006.01) Medicinal preparations containing peptides - Albumins

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

3 February 2011 PCT application entered the National Phase

  PCT publication WO2009/158033 Priority application(s): WO2009/158033

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009262970-Methods for dosing an activin-ActRIIa antagonist and monitoring of treated patients

2009262967-Patches and methods for the transdermal delivery of a therapeutically effective amount of iron